Background and Objectives: Hypertension and diabetes mellitus are major risk factors of endstage renal disease (ESRD). This study aimed to determine the prevalence of hypertension and diabetes mellitus among haemodialysis patients at Elobeid haemodialysis unit.
INTRODUCTION
End -Stage Renal Disease (ESRD) is a growing problem worldwide and renal replacement therapy is exerting an increasing pressure on health systems. The situation is particularly serious in developing countries where health resources are limited. Approximately 30% -40% of all patients with diabetes mellitus will develop nephropathy and many will progress to ESRD, necessitating dialysis or kidney transplantation [1] . Hypertension is highly prevalent in dialysis patients. At initiating of dialysis 80% of patients are hypertensive [2] .
Haemodialysis unit at Elobied hospital was established in the year 2002 and provides haemodialysis services to a large catchment area including patients from North Kordofan State, Southern Kordofan state, and West Kordofan state.
This study aimed to determine the prevalence of hypertension and diabetes mellitus among haemodialysis patients at Elobeid haemodialysis unit.
PATIENTS AND METHODS
The study was a single centre cross sectional study including 130 patients on chronic haemodialysis at Elobeid hospital haemodialysis unit. Each patient was personally interviewed in the haemodialysis unit using a structured questionnaire prepared by the investigators. Data collected include: socioeconomic data (gender, age, residence, and occupation), history of hypertension, diabetes mellitus, and treatment of hypertension, treatment of diabetes mellitus, duration of hypertension, duration of diabetes mellitus and duration of dialysis. Hypertension was defined as blood pressure ≥ 140/90 or the use of antihypertensive medications. Diabetes mellitus is defined by use of insulin therapy. In this study both hypertension and daibetesv mellitus were already diagnosed and on regular medications. Statistic package for social sciences (SPSS) version 20 was used for data analysis.
RESULTS
More than two thirds of patients were males with male to female ratio of 2.2: 1. The mean age was 46.3± 17.8 years. Forty two (32%) patients were above 56 years of age Table 1 .
Ninety eight (75%) patients were hypertensive, the majority of hypertensive patients were males (90%). Eighty six hypertensive patients were on calcium channel blocker (88%). Amlodipine was the commonly used antihypertensive used (Table 2 ). 25 (19%) patients were diabetics and all of them were males. All diabetic patients were also hypertensive (Table 3 ). 14 diabetic patients (56%) were on insulin therapy, while 11 patients were using metformin.
All diabetic patients included in this study were worker, while all workers, housewives and employees included in this study were all hypertensive (Table 4) .
More than two thirds of patients were urban (72%) ( Table 5 ). The majority of hypertensive patients and all diabetic patients were urban. 
DISCUSSION
Hypertension is common in patients with advanced stages of chronic kidney disease (CKD) and its prevalence remains very high in patients with end stage renal disease (ESRD) treated with haemodialysis. There is larger frequency of hypertension even in non-dialyzed patients as renal function declines. Systolic hypertension with or without diastolic hypertension is a major problem in haemodialysis patients, although isolated diabetic hypertension is uncommon [3] . In this study ninety eight (75%) patients were hypertensive. The prevalence of hypertension in this study is a little pit lower than that reported by Gorsane, et at, who reported that the prevalence of hypertension among haemodialysis patents was 90% [4] . Unfortunately most of our haemodialysis patients became too late with end -stage renal failure, and therefore it is impossible to differentiate between hypertension as a cause of chronic renal disease or a sequel to impaired renal function specially in the absence of previous patient records.
End -stage renal failure requiring dialysis is one of the most serious complications of diabetes mellitus and in developed countries, diabetes is considered as the common cause of chronic renal failure among patients who are starting dialysis [5] . Approximately 30% 40% of all patients with diabetes will develop nephropathy and many will progress to ESRD, necessitating dialysis or kidney transplant [6] . In this study 19% of haemodialysis patients were diabetics so the prevalence of diabetes among haemodialysis patients involved in this study is lower than what is previously mentioned [6] . Metformin has traditionally been regarded as contraindicated in chronic kidney disease (CKD), though guidelines in recent years have been relaxed to permit therapy if the glomerular filtration rate (GFR) is >30 ml/min [7, 8] . On the other hand the use of metformin in patients with type 2 diabetes mellitus and advanced chronic kidney disease (CKD) confers a 35% increased risk of all-cause mortality compared to those not treated with metformin [9] . All diabetic patients included in this study had advanced CKD and 11 diabetic patients were on metformin therapy and therefore they were advised to stop it. Hypertension is common among patients with chronic kidney disease and hypertension in the setting of diabetes is defined as a systolic blood pressure ≥ 130 mmHg or a diastolic blood pressure ≥ 80 mmHg [10] . In this study all diabetic haemodialysis patients were hypertensive. Table 2 . Control of hypertension in hypertensive dialysis patients is associated with improved survival. In this study 86 hypertensive patients were on calcium channel blocker (88%) and amlodipine was the commonly used antihypertensive drug. These results were similar to what had been mentioned by Rajiv [11].
CONCLUSION
The prevalence of hypertension among haemodialysis patients was high while the prevalence of diabetes is less than that reported globally. The blood pressure should be tidily controlled specially in diabetic patients and patients with impaired renal function.
For early detection of chronic kidney disease and elevated blood pressure as a sequel, routine blood pressure measurement is highly recommended in adult patients attend the clinic for any reason.
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